ENvue Medical IncFEED
Price$0.28

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $4.1M

Margins

Current

Quality Metrics

Earnings-Beat Rate50.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
ENvue
View details

Focusing on accelerating U.S. commercial adoption, pursuing pediatric and PICC clearances, and expanding at-home ENFit syringe distribution.

NanoVibronix
View details

Advancing acoustic therapeutics and expanding distribution, including leveraging UK Drug Tariff reimbursement for UroShield.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.